Open access
72
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials
John H Riley1 MDC Global Clinical Development – UK, GlaxoSmithKlineCorrespondence[email protected]
, Maggie Tabberer2 Value Evidence and Outcomes, GlaxoSmithKline, Uxbridge, Middlesex, UK
, Nathalie Richard3 Respiratory Medicines Development Center, GlaxoSmithKline, Durham, NC, USA
, Alison Donald3 Respiratory Medicines Development Center, GlaxoSmithKline, Durham, NC, USA
, Alison Church3 Respiratory Medicines Development Center, GlaxoSmithKline, Durham, NC, USA
& Stephanie S Harris3 Respiratory Medicines Development Center, GlaxoSmithKline, Durham, NC, USA
Pages 1873-1880
|
Published online: 12 Aug 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.